IL10 and colitis: More recently, in a trinitrobenzene sulfonate rat colitis model, the intravenous injection of MSC-EVs substantially reduced colonic damage and NF-κB activities, accompanied by decreased proinflammatory cytokines and increased IL-10 [126].